Business Context and Reporting Period
Company: McKesson Corporation
Filing Type: Form 8-K (Current Report)
Date of Report: January 13, 2020
Event: Regulation FD Disclosure regarding an upcoming appearance at the 38th Annual J.P. Morgan Healthcare Conference (January 14, 2020) and the issuance of an updated full-year fiscal 2020 forecast.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The document serves as a notice that an updated forecast for Adjusted Earnings per diluted share for full-year fiscal 2020 was issued in a press release (Exhibit 99.1), but the numerical details of that forecast are not contained within the body of this 8-K filing.
Material Changes
No material changes to historical financial results are reported in this document. The filing indicates a change in forward-looking guidance, specifically an updated forecast for Adjusted Earnings per diluted share for fiscal 2020, though the specific magnitude of this change is not detailed in the text.
Guidance, Outlook, and Risks
- Guidance Update: Management provided an updated forecast for Adjusted Earnings per diluted share for full-year fiscal 2020.
- Management Commentary: The update was issued in conjunction with the company's planned appearance at the J.P. Morgan Healthcare Conference.
- Legal Status: The information, including the press release, is furnished but not deemed "filed" for purposes of Section 18 of the Exchange Act and is not incorporated by reference unless expressly stated.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated January 13, 2020) for the specific numerical values of the updated Adjusted Earnings per diluted share forecast.
- Verify the rationale for the guidance update during the J.P. Morgan Healthcare Conference presentation.
- Confirm the definition of "Adjusted Earnings per diluted share" used in the updated forecast to ensure comparability with prior periods.